Istanbul Medipol University
Istanbul, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT07426731
This randomized controlled trial aims to compare the postoperative analgesic efficacy of ultrasound-guided Sacral Erector Spinae Plane (ESP) block versus Dorsal Penile Nerve Block (DPNB) in pediatric patients aged 1-7 years undergoing hypospadias surgery. The primary outcome is the pain score assessed by the FLACC scale at the 12th postoperative hour
Interested in participating?
Request Info1 year–7 year
Male
Interventional
Not applicable
Istanbul, Turkey (Türkiye)
Location status: Recruiting
Hypospadias surgery in pediatric patients can cause significant postoperative pain. While Dorsal Penile Nerve Block (DPNB) is a standard regional technique, the Sacral Erector Spinae Plane (ESP) block has emerged as a potential alternative for trunk and pelvic analgesia.
In this prospective, randomized, double-blind study, 70 pediatric patients (ASA I-II, aged 1-7 years) will be randomly assigned to receive either a Sacral ESP block or a DPNB under general anesthesia. Both blocks will be performed under ultrasound guidance using 0.25% bupivacaine, administered at a volume of 0.4 mL/kg for the Sacral ESP block and 0.4 mL/kg for the DPNB.
Postoperative pain will be assessed using the FLACC (Face, Legs, Activity, Cry, Consolability) scale at 30 minutes, 1, 2, 6, 12, and 24 hours. The study aims to determine if Sacral ESP provides superior or non-inferior analgesia compared to DPNB, specifically focusing on the 12th-hour pain scores, total analgesic consumption, and time to first rescue analgesic
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be placed in the lateral decubitus position. Under ultrasound guidance, the plane between the multifidus muscle and the sacral lamina (erector spinae plane) will be identified at the sacral level. A total of 0.4 mL/kg of 0.25% Bupivacaine will be injected bilaterally
Patients will be in the supine position. Under ultrasound guidance, the needle will be advanced under Buck's fascia at the penile base (pubic symphysis level). A total of 0.4 mL/kg of 0.25% Bupivacaine will be injected bilaterally
Time frame: 30 minutes, 1, 2, 4, 6, 12 and 24 hours post-surgery
Pain severity assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale at 30 minutes, 1, 2, 4, 6, 12 and 24 hours. The total score ranges from 0 to 10, where higher scores indicate worse pain.
Time frame: 24 hours post-surgery
The cumulative amount of rescue analgesics (mg) consumed.
Time frame: Up to 24 hours
Presence of motor block, urinary retention, hematoma/ecchymosis at injection site, vomiting, or pruritus.
Time frame: 30 minutes, 1, 2, 4, 6, 12 and 24 hours post-surgery
Pain severity assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale at 30 minutes, 1, 2, 4, 6, 12 and 24 hours. The total score ranges from 0 to 10, where higher scores indicate worse pain.
Contact information is provided by the study sponsor or research team.
Medipol University
Other
Comparison of the Effects of Sacral Erector Spinae Plane Block and Dorsal Penile Nerve Block on Postoperative Pain Management in Pediatric Patients Undergoing Hypospadias Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07619651
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT07575204
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Dhaka, Bangladesh
View Trial DetailsNCT04215874
Agnosia, Congenital Abnormalities
Istanbul, Şişli, Turkey (Türkiye)
View Trial DetailsNCT03902249
Agnosia, Congenital Abnormalities
View Trial Details